CDMOs Step Up Parenteral Manufacturing Support

Throughout the pandemic, CDMOs of all sizes and capabilities stepped in to fulfil industry needs, providing the capabilities and capacities for the manufacture of essential medicines.

EXECUTIVE INTERVIEW: Broadening Our Biologics Footprint, Together

At the end of 2021, PCI Pharma Services acquired Lyophilization Services of New England, Inc. (LSNE), expanding PCI’s breadth of services as a global CDMO, building on its expertise in specialty manufacturing and packaging at both clinical and ...

Managing Demand: Key Factors in Clinical and Commercial Outsourcing

The demand for biologics, and the ubiquitous use of highly potent ingredients, is forcing the industry to adapt their processes and consider alternative options, such as outsourcing and integrated solutions

Solid-Dose Packaging Trends

Solid-dosage forms continue to play an essential role in the pharmaceutical marketplace despite the attention the COVID-19 pandemic has focused on parenteral products.

Discussing Advancements in Oncology with Tim Roberts

Tim Roberts, Chief Commercial Officer, sat down with Pharma’s Almanac’s Scientific Editor in Chief David Alvaro to discuss the advancements in oncology, the impact of COVID-19 on the industry, and why PCI is well-positioned to be a successful company

Vaccinating the Globe: Choosing the right CDMO Partner.

The year is 2030, a new variant of the latest virus-X is highly contagious and circulating globally. Alexa has just notified you that your custom-made vaccine strips have been dispatched and will arrive today between 9 and 9:15 a.m.

The trusted partner for global integrated CDMO services.

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Start your PCI experience today.

Your bridge between life-changing therapies and patients.